pyrimethamine has been researched along with Abortion, Tubal in 13 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adequate prevention regimen with monthly sulfadoxine-pyrimethamine given to all pregnant women has been proved to reduce the risk of LBW in malaria endemic areas." | 9.69 | Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial. ( Derra, K; Donnen, P; Dramaix, M; Kaboré, B; Lingani, M; Robert, A; Rouamba, T; Samadoulougou, S; Sanou, M; Somé, G; Sorgho, H; Tahita, MC; Tinto, H; Valéa, I; Zango, SH, 2023) |
| "In the context of the increasing resistance to sulfadoxine-pyrimethamine (SP), we evaluated the efficacy of mefloquine (MQ) for intermittent preventive treatment during pregnancy (IPTp)." | 9.14 | Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. ( Ayemonna, P; Bottero, J; Briand, V; Cordel, H; Cot, M; Fayomi, B; Fievet, N; Guerra, J; Kossou, H; Masse, V; Massougbodji, A; Noël, H, 2009) |
| "The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa." | 8.98 | Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018) |
| "Data were collected from two separate prospective cohorts to ascertain the safety of chloroquine-proguanil, sulfadoxine-pyrimethamine (SP), and mefloquine taken in the first trimester of pregnancy." | 7.70 | Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. ( Edwards, R; Fuchs, E; Kerr, L; Phillips-Howard, PA; Schildknecht, J; Steffen, R; Vanhauwere, B, 1998) |
| "Adequate prevention regimen with monthly sulfadoxine-pyrimethamine given to all pregnant women has been proved to reduce the risk of LBW in malaria endemic areas." | 5.69 | Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial. ( Derra, K; Donnen, P; Dramaix, M; Kaboré, B; Lingani, M; Robert, A; Rouamba, T; Samadoulougou, S; Sanou, M; Somé, G; Sorgho, H; Tahita, MC; Tinto, H; Valéa, I; Zango, SH, 2023) |
| "In the context of the increasing resistance to sulfadoxine-pyrimethamine (SP), we evaluated the efficacy of mefloquine (MQ) for intermittent preventive treatment during pregnancy (IPTp)." | 5.14 | Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. ( Ayemonna, P; Bottero, J; Briand, V; Cordel, H; Cot, M; Fayomi, B; Fievet, N; Guerra, J; Kossou, H; Masse, V; Massougbodji, A; Noël, H, 2009) |
| "In Mali, IPT with SP appears more efficacious than weekly chloroquine chemoprophylaxis in preventing malaria during pregnancy." | 5.11 | Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. ( Coulibaly, D; Doumbo, O; Doumtabe, D; Kayentao, K; Keita, AS; Kodio, M; Maiga, B; Maiga, H; Mungai, M; Newman, RD; Ongoiba, A; Parise, ME, 2005) |
| "The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa." | 4.98 | Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018) |
| "Data were collected from two separate prospective cohorts to ascertain the safety of chloroquine-proguanil, sulfadoxine-pyrimethamine (SP), and mefloquine taken in the first trimester of pregnancy." | 3.70 | Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. ( Edwards, R; Fuchs, E; Kerr, L; Phillips-Howard, PA; Schildknecht, J; Steffen, R; Vanhauwere, B, 1998) |
| "Toxoplasmosis is a ubiquitous protozoal infection that during pregnancy commonly affects the fetus severely, with maternal infection usually being mild self-limiting." | 1.40 | An unusual case of disseminated toxoplasmosis in a previously healthy pregnant patient: radiographic, CT, and MRI findings. ( Jain, H; Kadavigere, R; Narayanan, R; Paruthikunnan, S; Prabhu, M; Shankar, B, 2014) |
| "Toxoplasmosis was detected in those persons having lymphadenitis, therapeutical patients, women with aggravated obstetrical history having had spontaneous abortions and having given birth to sick children, patients with sluggish meningoencephalitis presenting with epileptoid and hypothalamic syndrome, polyneuritis, and patients with myopia, chorioretinitis and uveitis." | 1.31 | [Toxoplasmosis in sick persons]. ( Netrebko, ID, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Lingani, M | 1 |
| Zango, SH | 1 |
| Valéa, I | 1 |
| Samadoulougou, S | 1 |
| Somé, G | 1 |
| Sanou, M | 1 |
| Kaboré, B | 1 |
| Rouamba, T | 1 |
| Sorgho, H | 1 |
| Tahita, MC | 1 |
| Derra, K | 1 |
| Dramaix, M | 1 |
| Tinto, H | 1 |
| Donnen, P | 1 |
| Robert, A | 1 |
| González, R | 1 |
| Pons-Duran, C | 1 |
| Piqueras, M | 1 |
| Aponte, JJ | 1 |
| Ter Kuile, FO | 1 |
| Menéndez, C | 1 |
| Paruthikunnan, S | 1 |
| Shankar, B | 1 |
| Kadavigere, R | 1 |
| Prabhu, M | 1 |
| Narayanan, R | 1 |
| Jain, H | 1 |
| Briand, V | 1 |
| Bottero, J | 1 |
| Noël, H | 1 |
| Masse, V | 1 |
| Cordel, H | 1 |
| Guerra, J | 1 |
| Kossou, H | 1 |
| Fayomi, B | 1 |
| Ayemonna, P | 1 |
| Fievet, N | 1 |
| Massougbodji, A | 1 |
| Cot, M | 1 |
| Netrebko, ID | 1 |
| Kayentao, K | 1 |
| Kodio, M | 1 |
| Newman, RD | 1 |
| Maiga, H | 1 |
| Doumtabe, D | 1 |
| Ongoiba, A | 1 |
| Coulibaly, D | 1 |
| Keita, AS | 1 |
| Maiga, B | 1 |
| Mungai, M | 1 |
| Parise, ME | 1 |
| Doumbo, O | 1 |
| Phillips-Howard, PA | 1 |
| Steffen, R | 1 |
| Kerr, L | 1 |
| Vanhauwere, B | 1 |
| Schildknecht, J | 1 |
| Fuchs, E | 1 |
| Edwards, R | 1 |
| Miller, EC | 1 |
| Cengir, SD | 1 |
| Ortaç, F | 1 |
| Söylemez, F | 1 |
| Fuchs, F | 1 |
| Kimball, AC | 1 |
| Kean, BH | 1 |
| Hoffbauer, H | 1 |
| Struck, E | 1 |
| Voss, H | 1 |
| Werner, H | 1 |
| Hogan, MJ | 1 |
| Iygiste, AK | 1 |
| Zasukhin, DN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intermittent Preventive Treatment During Pregnancy in Benin: a Randomized, Open, and Equivalent Trial Comparing Sulfadoxine-Pyrimethamine With Mefloquine[NCT00274235] | Phase 3 | 1,600 participants (Anticipated) | Interventional | 2005-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for pyrimethamine and Abortion, Tubal
| Article | Year |
|---|---|
Mefloquine for preventing malaria in pregnant women.
Topics: Abortion, Spontaneous; Africa South of the Sahara; Antimalarials; Dizziness; Drug Combinations; Drug | 2018 |
Ocular toxoplasmosis.
Topics: Abortion, Spontaneous; Adult; Animals; Diagnosis, Differential; Eye Diseases; Female; Humans; Hypers | 1969 |
[Current status of research on the prevention of congenital toxoplasmosis].
Topics: Abortion, Spontaneous; Animals; Antibodies; Child, Preschool; Chlortetracycline; Complement Fixation | 1971 |
3 trials available for pyrimethamine and Abortion, Tubal
| Article | Year |
|---|---|
Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial.
Topics: Abortion, Spontaneous; Antimalarials; Azithromycin; Birth Weight; Burkina Faso; Drug Combinations; F | 2023 |
Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antimalarials; Drug Combinations; Female; | 2009 |
Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anemia; Birth Weight; Chemoprevention; Chloroquine; Drug A | 2005 |
7 other studies available for pyrimethamine and Abortion, Tubal
| Article | Year |
|---|---|
An unusual case of disseminated toxoplasmosis in a previously healthy pregnant patient: radiographic, CT, and MRI findings.
Topics: Abortion, Spontaneous; Adult; Antimalarials; Brain; Clindamycin; Diagnosis, Differential; Female; Hu | 2014 |
[Toxoplasmosis in sick persons].
Topics: Abortion, Spontaneous; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Co | 2002 |
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; | 1998 |
[The significance of toxoplasmosis in pregnancy].
Topics: Abortion, Spontaneous; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectio | 1977 |
Treatment and results of chronic toxoplasmosis. Analysis of 33 cases.
Topics: Abortion, Spontaneous; Female; Fetal Death; Humans; Obstetric Labor, Premature; Pregnancy; Pregnancy | 1992 |
The management of toxoplasmosis in pregnancy.
Topics: Abortion, Spontaneous; Abortion, Therapeutic; Female; Humans; Infant; Infant, Newborn; Leucovorin; P | 1974 |
[Demonstration of toxoplasma in the menstrual blood using the immunofluorescence technic].
Topics: Abortion, Spontaneous; Blood; Female; Fluorescent Antibody Technique; Gestational Age; Humans; Infan | 1969 |